Lead signal
GN
Good News Network
Jun 9, 2026Breakthrough research
Breakthrough researchCommunity impact
Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testin...
Story tags
#community